Countries covered: United States
Introduction:
Through 2015, the US peripheral vascular (PV) device market will grow steadily as a result of increased adoption of minimally invasive treatment options for peripheral vascular disease (PVD) and new technologies that encourage physician adoption of PV devices in a greater patient population. Clinical trials will become increasingly important as manufacturers seek vascular-indication approval for their devices and discussions related to US health care reforms illuminate the comparative effectiveness of different treatment options. Threats to reimbursement will, however, curb potential revenues as physicians become more conservative in their use of premium-priced devices or multiple-device treatments. Nevertheless, growing awareness of PVD and physician interest in treating the disease will spur considerable market growth through 2015, generating revenues of over $3 billion by the end of the forecast period.
Questions Answered in This Report:
- Although drug-eluting stents (DES) account for a significant portion of coronary stenting procedures in the US, there are no devices approved for peripheral use. Several manufacturers are evaluating the use of DES in the lower extremities through clinical trials, and it is expected that at least one DES product will be approved and launched in the US in 2011. How will the expected approval of peripheral DES affect the PV stent market? What kind of penetration rates will peripheral DES achieve in the US?
- The highly anticipated CREST (Carotid Revascularization Endarterectomy versus Stent Trial) released preliminary data in early 2010. How has this data been received by the industry? What impact will this have on the carotid stent market? What barriers are still in place before Centers for Medicare & Medicaid Services will expand reimbursement?
- Atherectomy has emerged in recent years as an alternative method for debulking plaque, particularly in the lower-extremity arteries. What controversies remain regarding the use of atherectomy? How will the use of atherectomy as a stand-alone treatment for peripheral artery disease change through 2015? Will the procedure continue to be performed in conjunction with stenting?
- Thoracic aortic stent grafts have been a key area of innovation for device manufacturers due to their rapid adoption of this technology. How will newer technologies expand the treatable patient population and contribute to market growth? Which new competitors are expected to enter the US market?
Scope:
Regions covered: US
Procedure segmentation: Our analysis uses the following breakdown of procedures:
- PV stenting
- By indication (carotid, renal, iliac, femoropopliteal, infrapopliteal, venous and other [subclavian, brachial, and mesenteric arteries, along with arteriovenous (AV) access and transjugular intrahepatic portosystemic shunt (TIPS)])
- By stent type (self-expandable [SX], balloon-expandable [BX], covered, and drug-eluting [forecasted])
- Percutaneous transluminal angioplasty (PTA) balloon catheters
- By type (plain old balloon angioplasty and PTA-with-stent)
- By indication (carotid, renal, iliac, femoropopliteal, infrapopliteal, AV, and other [subclavian and venous])
- Atherectomy devices
- By type (stand-alone and adjunctive with stent or balloon)
- By indication (femoropopliteal, infrapopliteal, and other [iliac, carotid, and renal])
- Aortic stent grafts
- By indication (abdominal aortic and thoracic aortic)
- Synthetic surgical grafts
- By indication (abdominal aortic, thoracic aortic, aorto-iliac, extra-anatomical, above-the-knee bypass, below-the-knee bypass, AV, and other PV [cervical, vertebral, visceral, and upper-extremity arteries])
Market segmentation: Our analysis uses the following breakdown of the market:
- PV stents
- By indication (carotid, renal, iliac, femoropopliteal, infrapopliteal, venous and other [subclavian, brachial, and mesenteric arteries, along with AV access and TIPS])
- By stent type (SX, BX, covered, and drug-eluting [forecasted])
- PTA balloon catheters
- By balloon type (standard, small, high-pressure, large, and specialty)
- Atherectomy devices
- By device type (rotational and laser)
- Embolic protection devices
- By indication (carotid, renal, and other [use during atherectomy])
- Aortic stent grafts
- By indication (abdominal aortic and thoracic aortic)
- Synthetic surgical grafts
- By indication (abdominal aortic, thoracic aortic, aorto-iliac, extra-anatomical, above-the-knee bypass, below-the-knee bypass, AV, and other PV [cervical, vertebral, visceral, and upper-extremity arteries])
- By graft material (expanded polytetrafluoroethylene [ePTFE], Dacron, and biologic)
- Accessory devices
- By device type (guidewires [interventional, hydrophilic, and diagnostic], sheaths [introducer and guiding], diagnostic catheters [standard and hydrophilic], guiding catheters, and chronic total occlusion crossing devices)
Market forecast features: Based on primary research with industry professionals, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, average selling prices, and market values over a 7-year period (2009-2015).
Competitive analysis: We provide a detailed analysis of the competitive landscape in the market, as well as market shares and qualitative discussions of the leading competitors in each market segment.
|
- EXECUTIVE SUMMARY
- METHODOLOGY
- 1.0 PERIPHERAL VASCULAR DISEASE OVERVIEW
- 1.1 Disease Overview
- 1.2 Device Overview
- 1.2.1 Peripheral Vascular Stents
- 1.2.2 PTA Balloon Catheters
- 1.2.3 Atherectomy Devices
- 1.2.4 Embolic Protection Devices
- 1.2.5 Aortic Stent Grafts
- 1.2.6 Synthetic Surgical Grafts
- 1.2.7 Accessory Devices
- 1.3 Indication Overview
- 1.3.1 Carotid Artery
- 1.3.2 Renal Artery
- 1.3.3 Iliac Artery
- 1.3.4 Lower Extremities: Femoropopliteal and Infrapopliteal Arteries
- 1.3.5 Aorta
- 1.3.5.1 Abdominal Aorta
- 1.3.5.2 Thoracic Aorta
- 1.3.6 Arteriovenous Access
- 1.3.7 Venous
- 2.0 PERIPHERAL VASCULAR DEVICEMARKET
- 2.1 Market Overview
- 2.2 Market Analysis
- 2.2.1 Key Report Updates
- 2.2.2 Procedures
- 2.2.2.1 Carotid Procedures by Type
- 2.2.2.2 Renal Procedures by Type
- 2.2.2.3 Iliac Procedures by Type
- 2.2.2.4 Femoropopliteal Procedures by Type
- 2.2.2.5 Infrapopliteal Procedures by Type
- 2.2.3 Market Forecast
- 2.2.4 Market Drivers and Limiters
- 2.3 Competitive Analysis
- 2.3.1 Market Shares
- 3.0 PERIPHERAL VASCULAR STENTMARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Procedures by Indication
- 3.2.1.1 Carotid Artery Stenting
- 3.2.1.2 Renal Artery Stenting
- 3.2.1.3 Iliac Artery Stenting
- 3.2.1.4 Femoropopliteal Stentin
- 3.2.1.5 Infrapopliteal Stenting
- 3.2.1.6 Venous Stenting
- 3.2.1.7 Other Indications for Peipheral Stenting
- 3.2.2 Procedures by Stent Type
- 3.2.3 Market Forecast by Stent Type
- 3.2.3.1 Self Expandable Stent Market
- 3.2.3.2 Balloon Expandable Stent Market
- 3.2.3.3 Covered Stent Market
- 3.2.3.4 Forecasted Peripheral Drug Eluting Stent Market
- 3.2.4 Market Forecast by Indication
- 3.2.4.1 Carotid Artery Stenting Market
- 3.2.4.2 Renal Stenting Market
- 3.2.4.3 Iliac Stenting Market
- 3.2.4.4 Femoropopliteal Stenting Market
- 3.2.4.5 Infrapopliteal Stenting Market
- 3.2.4.6 Venous Stenting Market
- 3.2.4.7 Other Indication Stent Market
- 3.2.5 Market Drivers and Limiters
- 3.3 Competitive Analysis
- 3.3.1 Competitive Landscape
- 3.3.2 Market Shares
- 4.0 PTA BALLOON CATHETERMARKET
- 4.1 Market Overview
- 4.2 Market Analysis
- 4.2.1 Procedures by Type
- 4.2.2 Procedures by Indication
- 4.2.2.1 Carotid Artery PTAs
- 4.2.2.2 Renal Artery PTAs
- 4.2.2.3 Iliac Artery PTAs
- 4.2.2.4 Femoropopliteal Artery PTAs
- 4.2.2.5 Infrapopliteal Artery PTAs
- 4.2.2.6 Arteriovenous Access PTAs
- 4.2.2.7 Other Indication PTAs
- 4.2.3 Market Forecast by PTA Balloon Catheter Type
- 4.2.3.1 Standard PTA Balloon Catheter Market
- 4.2.3.2 Small PTA Balloon Catheter Market
- 4.2.3.3 High Pressure PTA Balloon Catheter Market
- 4.2.3.4 Specialty PTA Balloon Catheter Market
- 4.2.3.5 Large PTA Balloon Catheter Market
- 4.2.4 Market Drivers and Limiters
- 4.3 Competitive Analysis
- 4.3.1 Competitive Landscape
- 4.3.2 Market Shares
- 5.0 ATHERECTOMY DEVICEMARKET
- 5.1 Market Overview
- 5.2 Market Analysis
- 5.2.1 Procedures by Type
- 5.2.2 Procedures by Indication
- 5.2.3 Market Forecast by Device Type
- 5.2.3.1 Rotational Atherectomy Device Market
- 5.2.3.2 Laser Atherectomy Device Market
- 5.2.4 Market Drivers and Limiters
- 5.3 Competitive Analysis
- 5.3.1 Competitive Landscape
- 5.3.2 Market Shares
- 6.0 EMBOLIC PROTECTION DEVICEMARKET
- 6.1 Market Overview
- 6.2 Market Analysis
- 6.2.1 Procedures
- 6.2.1.1 Carotid Embolic Protection Procedures
- 6.2.1.2 Renal Embolic Protection Procedures
- 6.2.1.3 Lower Extremity Embolic Protection Procedures
- 6.2.2 Market Forecast
- 6.2.3 Market Drivers and Limiters
- 6.3 Competitive Analysis
- 6.3.1 Competitive Landscape
- 6.3.2 Market Shares
- 7.0 AORTIC STENT GRAFTMARKET
- 7.1 Market Overview
- 7.2 Market Analysis
- 7.2.1 Procedures
- 7.2.1.1 Abdominal Aortic Procedures
- 7.2.1.2 Thoracic Aortic Procedures
- 7.2.2 Market Forecast
- 7.2.2.1 Abdominal Aortic Stent Graft Market
- 7.2.2.2 Thoracic Aortic Stent Graft Market
- 7.2.3 Market Drivers and Limiters
- 7.3 Competitive Analysis
- 7.3.1 Competitive Landscape
- 7.3.2 Market Shares
- 8.0 SYNTHETIC SURGICAL GRAFTMARKET
- 8.1 Market Overview
- 8.2 Market Analysis
- 8.2.1 Procedures by Indication
- 8.2.1.1 Abdominal Aortic Surgical Graft Procedures
- 8.2.1.2 Thoracic Aortic Surgical Graft Proced
- 8.2.1.3 Aorto Iliac Bypass Procedure
- 8.2.1.4 Extra Anatomical Bypass Procedures
- 8.2.1.5 Peripheral Bypass Procedures
- 8.2.1.6 Other Indications
- 8.2.1.7 Arteriovenous Access
- 8.2.2 Market Forecast by Material
- 8.2.3 Market Forecast by Indication
- 8.2.3.1 Abdominal Aortic Surgical Graft Market
- 8.2.3.2 Thoracic Aortic Surgical Graft Market
- 8.2.3.3 Aorto Iliac Bypass Surgical Graft Market
- 8.2.3.4 Extra Anatomical Bypass Surgical Graft Market
- 8.2.3.5 Peripheral Bypass Surgical Graft Market
- 8.2.3.6 Other Indications Surgical Graft Market
- 8.2.3.7 Arteriovenous Access Surgical Graft Market
- 8.2.4 Market Drivers and Limiters
- 8.3 Competitive Analysis
- 8.3.1 Competitive Landscape
- 8.3.2 Market Shares
- 9.0 ACCESSORY DEVICEMARKET
- 9.1 Market Overview
- 9.2 Market Analysis
- 9.2.1 Procedures
- 9.2.1.1 Accessory Device Overview
- Guidewires
- Sheaths
- Diagnostic Catheters
- Guiding Catheters
- CTO Crossing Devices
- 9.2.2 Market Forecast
- 9.2.2.1 Guidewire Market
- 9.2.2.2 Sheath Market
- 9.2.2.3 Diagnostic Catheter Market
- 9.2.2.4 Guiding Catheter Market
- 9.2.2.5 CTO Crossing Device Market
- 9.2.3 Market Drivers and Limiters
- 9.3 Competitive Analysis
- 9.3.1 Competitive Landscape
- 9.3.2 Market Shares
- 10.0 PERIPHERAL VASCULAR DEVICEMARKET COMPETITIVE ANALYSIS
- 10.1 Competitive Landscape
- 10.1.1 Market Shares
- 10.2 Competitor Discussions (in Alphabetical Order)
- Abbott Vascular
- AngioDynamics
- Atrium Medical
- Boston Scientific
- Cardiovascular Systems Inc.
- Cook Medical
- Cordis
- C. R. Bard
- Endologix
- ev3 (acquired by Covidien)
- IDev Technologies
- Invatec (acquired by Medtronic)
- LeMaitre Vascular
- MAQUET
- Medtronic
- Pathway Medical Technologies
- Spectranetics
- Terumo Medical
- W. L. Gore
- Other
- 10.2.1 Emerging Competitors
- Aptus Endosystems
- Bolton Medical
- Nicast
- TriVascular2
- APPENDIX A: MRG ACRONYMS AND INITIALISMS
- APPENDIX B: SUPPLEMENTAL FIGURES
- LIST OF FIGURES AND TABLES
- EXECUTIVE SUMMARY
- Figure 1: PV Device Market, US (US$), 2009-2015
- Figure 2: PV Stent Procedures, by Stent Type, as a % of Total, US, 2009-2015
- Figure 3: PTA Balloon Catheter Procedures, by Procedure Type, US, 2009-2015
- Figure 4: Atherectomy Device Market, US (US$), 2009-2015
- Figure 5: EPD Market Growth, US, 2010-2015
- Figure 6: Aortic Stent Graft Penetration, by Indication, US, 2009-2015
- Figure 7: Synthetic Surgical Graft Market, by Material, US (US$), 2009-2015
- Figure 8: PV Accessory Device Market, by Device Type, US (US$), 2009-2015
- Table 1: Companies Mentioned in This Report
- METHODOLOGY
- Table 2: ICD 9 Procedure Codes and Descriptions
- 1.0 PERIPHERAL VASCULAR DISEASE OVERVIEW
- 2.0 PERIPHERAL VASCULAR DEVICEMARKET
- Figure 9: PV Device Market, by Device Type, US (US$), 2009-2015
- Table 3: Key Report Updates, 2011
- Table 4: PV Procedures, by Type, US, 2009-2015
- Table 5: PV Procedures, by Device Type, US, 2009-2015
- Table 6: Minimally Invasive Carotid Artery Procedures, by Type, US, 2009-2015
- Table 7: Minimally Invasive Renal Artery Procedures, by Type, US, 2009-2015
- Table 8: Minimally Invasive Iliac Artery Procedures, by Type, US, 2009-2015
- Table 9: Minimally Invasive Fem Pop Procedures, by Type, US, 2009-2015
- Table 10: Minimally Invasive Infrapop Procedures, by Type, US, 2009-2015
- Table 11: PV Device Market, by Device Type, US (US$), 2009-2015
- Table 12: Drivers of the PV Device Market, US
- Table 13: Limiters of the PV Device Market, US
- Table 14: Leading Competitors in the PV Device Market, by Device Type, as a % of Total, US, 2010
- 3.0 PERIPHERAL VASCULAR STENTMARKET
- Figure 10: PV Stent Market, by Indication, US (US$), 2009-2015
- Figure 11: PV Stent Procedures, by Indication, US, 2009-2015
- Table 15: PV Stent Procedures and Units, by Indication, US, 2009-2015
- Table 16: PV Stent Procedure and Unit Growth, by Indication, US, 2010-2015
- Table 17: Clinical Trial Summaries for Fem Pop Stenting, 2010
- Table 18: PV Stent Units, by Indication and Stent Type, US, 2010
- Table 19: PV Stent Units, by Stent Type and Indication, as a % of Total, US, 2010
- Table 20: PV Stent Procedures and Units, by Stent Type, US, 2009-2015
- Table 21: PV Stent Procedure and Unit Growth, by Stent Type, US, 2010-2015
- Table 22: PV Stent Market, by Stent Type, US (US$), 2009-2015
- Table 23: PV Stent Market Growth, by Stent Type, US, 2010-2015
- Table 24: PV Stent Market, by Stent Type, as a % of Total, US, 2009-2015
- Table 25: PV Stent Market, by Indication, US (US$), 2009-2015
- Table 26: PV Stent Market Growth, by Indication, US, 2010-2015
- Table 27: PV Stent Market, by Indication, as a % of Total, US, 2009-2015
- Table 28: CAS Market Forecast Assumptions, US, 2010
- Table 29: CAS Market, US (US$), 2009-2015
- Table 30: Alternate CAS Market, US (US$), 2009-2015
- Table 31: Renal Artery Stenting Market, US (US$), 2009-2015
- Table 32: Alternate Renal Artery Stenting Market, US (US$), 2009-2015
- Table 33: Iliac Artery Stenting Market, US (US$), 2009-2015
- Table 34: Fem Pop Stenting Market, US (US$), 2009-2015
- Table 35: Infrapop Stenting Market, US (US$), 2009-2015
- Table 36: Venous Stenting Market, US (US$), 2009-2015
- Table 37: Other Indication Stenting Market, US (US$), 2009-2015
- Table 38: Drivers of the PV Stent Market, US
- Table 39: Limiters of the PV Stent Market, US
- Table 40: Leading Competitors in the PV Stent Market, by Stent Type, as a % of Total, US, 2010
- Table 41: Leading Competitors in the PV Stent Market, by Indication, as a % of Total, US, 2010
- 4.0 PTA BALLOON CATHETERMARKET
- Figure 12: PTA Balloon Catheter Market, by Device Type, US (US$), 2009-2015
- Table 42: PTAs, by Indication, US, 2009-2015
- Table 43: POBAs, by Indication, US, 2009-2015
- Table 44: PTA with Stent Procedures, by Indication, US, 2009-2015
- Table 45: Primary Indications for PTA Balloon Catheters, by Device Type
- Table 46: PTA Balloon Catheter Market, by Device Type, US (US$), 2009-2015
- Table 47: PTA Balloon Catheter Market Growth, by Device Type, US, 2010-2015
- Table 48: PTA Balloon Catheter Market, by Device Type, as a % of Total, US, 2009-2015
- Table 49: Drivers of the PTA Balloon Catheter Market, US
- Table 50: Limiters of the PTA Balloon Catheter Market, US
- Table 51: Leading Competitors in the PTA Balloon Catheter Market, by Device Type, as a % of Total, US, 2010
- 5.0 ATHERECTOMY DEVICEMARKET
- Figure 13: Atherectomy Device Market, by Device Type, US (US$), 2009-2015
- Figure 14: Atherectomies, by Type, US, 2009-2015
- Table 52: Atherectomies, by Type, US, 2009-2015
- Table 53: Atherectomies, by Indication, US, 2009-
- Table 54: Atherectomy Device Market, by Device Type, US (US$), 2009-2015
- Table 55: Atherectomy Device Market Growth, by Device Type, US, 2010-2015
- Table 56: Atherectomy Device Market, by Device Type, as a % of Total, US, 2009-2015
- Table 57: Drivers of the Atherectomy Device Market, US, 2010
- Table 58: Limiters of the Atherectomy Device Market, US, 2010
- Table 59: Leading Competitors in the Atherectomy Device Market, by Device Type, as a % of Total, US, 2010
- 6.0 EMBOLIC PROTECTION DEVICEMARKET
- Figure 15: EPD Market, by Indication, US (US$), 2009-2015
- Figure 16: EPD Procedures, by Indication, as a % of Total, US, 2009-2015
- Table 60: EPD Procedures, by Indication, US, 2009-2015
- Table 61: EPD Market, by Indication, US (US$), 2009-2015
- Table 62: EPD Market Growth, by Indication, US, 2010-2015
- Table 63: EPD Market, by Indication, as a % of Total, US, 2009-2015
- Table 64: Drivers of the EPD Market, US, 2010
- Table 65: Limiters of the EPD Market, US, 2010
- Table 66: Leading Competitors in the EPD Market, by Indication, as a % of Total, US, 2010
- 7.0 AORTIC STENT GRAFTMARKET
- Figure 17: Aortic Stent Graft Market, by Indication, US (US$), 2009-2015
- Figure 18: Aortic Stent Graft Procedures, by Indication, US, 2009-2015
- Table 67: Aortic Repairs, by Indication, US, 2009-2015
- Table 68: Aortic Stent Graft Procedures and Units, by Indication, US, 2009-2015
- Figure 19: Abdominal Aortic Procedures, by Type, and Stent Graft Penetration, US, 2009-2015
- Figure 20: Thoracic Aortic Stent Graft Procedures, by Indication, as a % of Total, US, 2009-2015
- Figure 21: Thoracic Aortic Procedures, by Type, and Stent Graft Penetration, US, 2009-2015
- Table 69: Thoracic Aortic Stent Graft Procedures, by Indication, US, 2009-2015
- Table 70: Aortic Stent Graft Market, by Indication, US (US$), 2009-2015
- Table 71: Aortic Stent Graft Market Growth, by Indication, US, 2010-2015
- Table 72: Aortic Stent Graft Market, by Indication, as a % of Total, US, 2009-2015
- Table 73: Drivers of the Aortic Stent Graft Market, US
- Table 74: Limiters of the Aortic Stent Graft Market, US
- Table 75: Leading Competitors in the Aortic Stent Graft Market, by Indication, as a % of Total, US, 2010 132
- 8.0 SYNTHETIC SURGICAL GRAFTMARKET
- Figure 22: Synthetic Surgical Graft Market, by Material, US (US$), 2009-2015
- Figure 23: Synthetic Surgical Graft Procedures, by Indication, US, 2009-2015
- Table 76: Synthetic Surgical Graft Procedures, by Indication, US, 2009-2015
- Table 77: Synthetic and Biologic Surgical Graft Market, by Material, US (US$), 2009-2015
- Table 78: Synthetic and Biologic Surgical Graft Market Growth, by Material, US, 2010-2015
- Table 79: Synthetic and Biologic Surgical Graft Market, by Material, as a % of Total, US, 2009-2015 _143
- Table 80: Synthetic and Biologic Surgical Graft Market, by Indication, US (US$), 2009-2015
- Table 81: Abdominal Aortic Surgical Graft Market, US (US$), 2009-2015
- Table 82: Thoracic Aortic Surgical Graft Market, US (US$), 2009-2015
- Table 83: Aorto Iliac Bypass Surgical Graft Market, US (US$), 2009-2015
- Table 84: Extra Anatomical Bypass Surgical Graft Market, US (US$), 2009-2015
- Table 85: Peripheral Bypass Surgical Graft Market, by Indication, US (US$), 2009-2015
- Table 86: Peripheral Bypass Surgical Graft Market Growth, by Indication, US, 2010-2015
- Table 87: Other PV Indication Surgical Graft Market, US (US$), 2009-2015
- Table 88: AV Access Surgical Graft Market, US (US$), 2009-2015
- Table 89: Drivers of the Synthetic Surgical Graft Market, US
- Table 90: Limiters of the Synthetic Surgical Graft Market, US
- Table 91: Leading Competitors in the Synthetic Surgical Graft Market, by Material, as a % of Total, US, 2010
- 9.0 ACCESSORY DEVICEMARKET
- Figure 24: PV Accessory Device Market, by Device Type, US (US$), 2009-2015
- Figure 25: PV Interventional and Diagnostic Only Procedures, by Type, US, 2009-2015
- Table 92: PV Interventional and Diagnostic Only Procedures, by Type, US, 2009-2015
- Table 93: PV Accessory Device Market, by Device Type, US (US$), 2009-2015
- Table 94: Guidewire Market, by Type, US (US$), 2009-2015
- Table 95: Guidewire Market Growth, by Type, US, 2010-2015
- Table 96: Guidewire Market, by Type, as a % of Total, US, 2009-2015
- Table 97: Sheath Market, by Type, US (US$), 2009-2015
- Table 98: Sheath Market Growth, by Type, US, 2010-2015
- Table 99: Sheath Market, by Type, as a % of Total, US, 2009-2015
- Table 100: Diagnostic Catheter Market, by Type, US (US$), 2009-2015
- Table 101: Diagnostic Catheter Market Growth, by Type, US, 2010-2015
- Table 102: Diagnostic Catheter Market, by Type, as a % of Total, US, 2009-2015
- Table 103: Guiding Catheter Market, by Type, US (US$), 2009-2015
- Table 104: CTO Crossing Device Market, US (US$), 2009-2015
- Table 105: Drivers of the PV Accessory Device Market, US
- Table 106: Limiters of the PV Accessory Device Market, US
- Table 107: Leading Competitors in the PV Accessory Device Market, by Device Type, US, 2010
- 10.0 PERIPHERAL VASCULAR DEVICEMARKET COMPETITIVE ANALYSIS
- Table 108: Leading Competitors in the PV Device Market, by Device Type, as a % of Total, US, 2009-2015
- APPENDIX A: MRG ACRONYMS AND INITIALISMS
- MRG Acronyms and Initialisms
- APPENDIX B: SUPPLEMENTAL FIGURES
- Figure 26: PV Device Market, US (US$), 2009-2015 (Detailed Format)
- Figure 27: PV Stent Procedures, by Stent Type, as a % of Total, US, 2009-2015 (Detailed Format) 202
- Figure 28: PTA Balloon Catheter Procedures, by Procedure Type, US, 2009-2015 (Detailed Format) 202
- Figure 29: Atherectomy Device Market, US (US$), 2009-2015 (Detailed Format)
- Figure 30: EPD Market Growth, US, 2010-2015 (Detailed Format)
- Figure 31: Aortic Stent Graft Penetration, by Indication, US, 2009-2015 (Detailed Format)
- Figure 32: Synthetic Surgical Graft Market, by Material, US (US$), 2009-2015 (Detailed Format)
- Figure 33: PV Accessory Device Market, by Device Type, US (US$), 2009-2015 (Detailed Format)
More United States Stents Reports
US Peripheral Vascular Devices Market - Present and Future Trends Until 2018 by
ABMRG
This research report provides key market trends, market forecasts and competitive scenario of the peripheral vascular devices (PVD) in the US through 2018. The ...
Global Markets for Coronary Stent Devices -- Focus on the Americas by
BCC Research
The global market for coronary stent devices reached $7.1 billion in 2011. By 2016, it is expected that total market value will reach $10.6 billion, ...
Peripheral Vascular Devices Market in the United States 2010-2014 by
Infiniti Research Limited
TechNavio’s analysts forecast the Peripheral Vascular Devices market in the US to grow at a CAGR of 3.2 percent over the period 2010-2014. One of ...
Freedonia Focus on Transdermal & Implantable Drug Delivery Systems by
Freedonia Focus
This report discusses US transdermal and implantable drug delivery systems for the years 2005 and 2010, with forecasts for 2015. Topics covered include market ...
US Peripheral Vascular Devices - Market Trend Till 2016 by
ABMRG
This market report provides vital market data on the peripheral vascular devices. The report also provides historic and forecasted market size in terms of value ($mn), ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Share this report
Other tasks Related Markets Stents Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
